Phathom Pharmaceuticals to Present at 20th Annual Needham Virtual Healthcare Conference

Rhea-AI Summary

Phathom Pharmaceuticals (Nasdaq: PHAT) announced participation in the 20th Annual Needham Virtual Healthcare Conference on April 13, 2021, at 10:15 a.m. ET. The management team will also hold one-on-one meetings during the event from April 12-15, 2021. For access to the live webcast and archived recording, visit the Phathom website. The company focuses on developing treatments for gastrointestinal diseases and has in-licensed vonoprazan, a potassium competitive acid blocker targeting acid-related disorders.

FLORHAM PARK, N.J., April 06, 2021 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced today that members of the management team will participate in a fireside chat at the 20th Annual Needham Virtual Healthcare Conference on Tuesday, April 13, 2021 at 10:15 a.m. ET.

Company management will also participate in one-on-one meetings during the virtual conference which runs from April 12-15, 2021.

To access the live webcast and archived recording of the presentation, visit the News & Events section of the Phathom website at https://investors.phathompharma.com/news-events/events-and-presentations. The recording will be available for 90 days following the event.

About Phathom
Phathom Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal diseases and disorders. Phathom has in-licensed the exclusive rights in the United States, Europe, and Canada to vonoprazan, a novel potassium competitive acid blocker (P-CAB) in late-stage development for the treatment of acid-related disorders. For more information about Phathom, visit the Company’s website at www.phathompharma.com or follow the Company on social media: LinkedIn at www.linkedin.com/company/phathompharma and Twitter @PhathomPharma.

CONTACTS

Media Contact:
Nick Benedetto
1-877-742-8466
media@phathompharma.com

Investor Contact:
Todd Branning
1-877-742-8466
ir@phathompharma.com

FAQ

When is Phathom Pharmaceuticals participating in the Needham Virtual Healthcare Conference?

Phathom Pharmaceuticals will participate on April 13, 2021, at 10:15 a.m. ET.

What is the schedule of the Needham Virtual Healthcare Conference for Phathom Pharmaceuticals?

The conference runs from April 12-15, 2021, with one-on-one meetings scheduled.

How can I access the Phathom Pharmaceuticals conference presentation?

The live webcast and archived recording will be available on the Phathom website.

What is vonoprazan and its significance to Phathom Pharmaceuticals?

Vonoprazan is a novel potassium competitive acid blocker in late-stage development for treating acid-related disorders.

What is Phathom Pharmaceuticals' focus in the biopharmaceutical industry?

Phathom Pharmaceuticals focuses on developing and commercializing treatments for gastrointestinal diseases.